Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Kras-Variant'
Kras-Variant published presentations and documents on DocSlides.
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
Targeting KRAS G12C in Solid Tumors
by morton
: . A . New Anticancer Approach . Marwan Fakih, ...
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
Department of GI Medical Oncology
by danika-pritchard
Does . the New EPOC trial . eliminate. . Anti. -...
Carcinosi peritoneale sincrona da carcinoma colorettale: ci
by calandra-battersby
Quale chemioterapia sistemica?. Dott. Giuseppe Co...
Molecular Subtypes:
by giovanna-bartolotta
Not Quite Ready . for Prime Time. Scott Kopetz, M...
Demonstrating Clinical Effectiveness of a Follow-On Companion Diagnostic Test When a New Clinical
by yoshiko-marsland
Abha. Sharma, Roche Molecular . Systems, May 201...
2597 REKA-TIMAVO FLOW SYSTEM IN KRAS/CARSO
by easyho
Seminar 2: . wednesday. . JuLY. 31, 2019. (LEARN...
Clinical Considerations in the Management of Metastatic Col
by danika-pritchard
Disease Progression. Program Goals. Introduction....
Dominika Kras
by alexa-scheidler
Sicily. Sicily is the largest island of the Medit...
No Does the New EPOC trial eliminate anti-EGFR antibodies a
by sherrill-nordquist
The New EPOC Study. Randomi. ze. Surgery. Oxalipl...
Of mice and men – Development of a mouse model for intrahepatic cholangiocarcinoma
by alexa-scheidler
Targeting BAP1 mutations in intrahepatic . cholan...
Challenges in RAS Wild-Type mCRC
by marina-yarberry
Introduction. Decision-Making Algorithm for First...
Josep Tabernero, MD PhD Medical Oncology Department Vall
by test
Josep Tabernero, MD PhD Medical Oncology Depa...
2SCIENTIFIC REPO 2020 109162 wvwvyzwvxvvz
by stella
dysregulated KRAS-RalB-NF-B is pathway was reporte...
A better clinical pathway for cancer monitoring
by BlessedBeyondMeasure
Antonius Schuh, Ph.D. | . Chief Executive Office...
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
by amelia
The NCI-H358 cells were treated with avutometinib ...
Load More...